These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26945147)

  • 1. Strategies to target HIV-1 in the central nervous system.
    Gray LR; Brew BJ; Churchill MJ
    Curr Opin HIV AIDS; 2016 Jul; 11(4):371-5. PubMed ID: 26945147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies.
    Gray LR; Cowley D; Welsh C; Lu HK; Brew BJ; Lewin SR; Wesselingh SL; Gorry PR; Churchill MJ
    Mol Psychiatry; 2016 Apr; 21(4):574-84. PubMed ID: 26303660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential of the CNS as a Reservoir for HIV-1 Infection: Implications for HIV Eradication.
    Fois AF; Brew BJ
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):299-303. PubMed ID: 25869939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research.
    Churchill MJ; Cowley DJ; Wesselingh SL; Gorry PR; Gray LR
    J Neurovirol; 2015 Jun; 21(3):290-300. PubMed ID: 25060300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.
    Bednar MM; Sturdevant CB; Tompkins LA; Arrildt KT; Dukhovlinova E; Kincer LP; Swanstrom R
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):262-71. PubMed ID: 25914150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the central nervous system a reservoir of HIV-1?
    Gray LR; Roche M; Flynn JK; Wesselingh SL; Gorry PR; Churchill MJ
    Curr Opin HIV AIDS; 2014 Nov; 9(6):552-8. PubMed ID: 25203642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of Latency as Part of a Cure for HIV-1.
    Rasmussen TA; Tolstrup M; Søgaard OS
    Trends Microbiol; 2016 Feb; 24(2):90-97. PubMed ID: 26690612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 persistence in the CNS: Mechanisms of latency, pathogenesis and an update on eradication strategies.
    Sonti S; Sharma AL; Tyagi M
    Virus Res; 2021 Oct; 303():198523. PubMed ID: 34314771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.
    Rose R; Nolan DJ; Maidji E; Stoddart CA; Singer EJ; Lamers SL; McGrath MS
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):3-8. PubMed ID: 28691499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV pharmacology: barriers to the eradication of HIV from the CNS.
    McGee B; Smith N; Aweeka F
    HIV Clin Trials; 2006; 7(3):142-53. PubMed ID: 16880170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which therapeutic strategy will achieve a cure for HIV-1?
    Cillo AR; Mellors JW
    Curr Opin Virol; 2016 Jun; 18():14-9. PubMed ID: 26985878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Immune System Mice for the Study of Human Immunodeficiency Virus-Type 1 Infection of the Central Nervous System.
    Evering TH; Tsuji M
    Front Immunol; 2018; 9():649. PubMed ID: 29670623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
    Kramer-Hämmerle S; Rothenaigner I; Wolff H; Bell JE; Brack-Werner R
    Virus Res; 2005 Aug; 111(2):194-213. PubMed ID: 15885841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shock and kill within the CNS: A promising HIV eradication approach?
    Nühn MM; Gumbs SBH; Buchholtz NVEJ; Jannink LM; Gharu L; de Witte LD; Wensing AMJ; Lewin SR; Nijhuis M; Symons J
    J Leukoc Biol; 2022 Nov; 112(5):1297-1315. PubMed ID: 36148896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to target non-T-cell HIV reservoirs.
    Sacha JB; Ndhlovu LC
    Curr Opin HIV AIDS; 2016 Jul; 11(4):376-82. PubMed ID: 27023285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?
    Rasmussen TA; Lewin SR
    Curr Opin HIV AIDS; 2016 Jul; 11(4):394-401. PubMed ID: 26974532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model for post-integration latency in macroglial cells to study HIV-1 reservoirs of the brain.
    Schneider M; Tigges B; Meggendorfer M; Helfer M; Ziegenhain C; Brack-Werner R
    AIDS; 2015 Jun; 29(10):1147-59. PubMed ID: 26035317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 infection and the developing nervous system: lineage-specific regulation of viral gene expression and replication in distinct neuronal precursors.
    Ensoli F; Wang H; Fiorelli V; Zeichner SL; De Cristofaro MR; Luzi G; Thiele CJ
    J Neurovirol; 1997 Aug; 3(4):290-8. PubMed ID: 9291237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidden HIV reservoirs: will eradication of the virus be possible?
    Gomez E
    Newsline People AIDS Coalit N Y; 1998 Mar; ():18-9. PubMed ID: 11367451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.